The role of n-3 PUFA-derived fatty acid derivatives and their oxygenated metabolites in the modulation of inflammation.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106351
Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106338
Prostaglandin D2-ethanolamide induces skin cancer apoptosis by suppressing the activity of cellular antioxidants.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.03.001
Oxysterols as lipid mediators: Their biosynthetic genes, enzymes and metabolites
来源期刊:Prostaglandins & Other Lipid MediatorsDOI:10.1016/j.prostaglandins.2019.106381
Mammary cancer risk and serum lipid profile of rats supplemented with pomegranate seed oil and bitter melon extract.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.03.005
Development of multitarget agents possessing soluble epoxide hydrolase inhibitory activity.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2018.12.003
Lysophosphatidic acid: Its role in bone cell biology and potential for use in bone regeneration.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106335
A strategy for validating concentrations of oxylipin standards for external calibration.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.02.006
Formation of trans-epoxy fatty acids correlates with formation of isoprostanes and could serve as biomarker of oxidative stress.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.04.004
Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106363
A JOURNEY OF CELECOXIB FROM PAIN TO CANCER.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106379
Effects of nonsteroidal anti-inflammatory drugs on the expression of arachidonic acid-metabolizing Cyp450 genes in mouse hearts, kidneys and livers.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.02.003
Cytochrome P450-Derived Eicosanoids and Inflammation in Liver Diseases.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106400
Lipid Mediators of Inflammation and Resolution in Individuals with Tuberculosis and Tuberculosis-Diabetes.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106398
PGE2 in fibrosis and cancer: Insights into fibroblast activation.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106339
Physiological and pathological levels of prostaglandin E2 in renal parenchyma and neoplastic renal tissue.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.02.004
Respective contribution of cytosolic phospholipase A2α and secreted phospholipase A2 IIA to inflammation and eicosanoid production in arthritis.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106340
BML-111, a lipoxin receptor agonist, protects against acute injury via regulating the renin angiotensin-aldosterone system.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2018.11.001
Parasitic load determination by differential expression of 5-Lipoxygenase and PGE2 Synthases in Visceral Leishmaniasis.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106390
The role of sphingosine 1-phosphate receptors on retinal pigment epithelial cells barrier function and angiogenic effects.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106365
Role of cytochrome P450-derived, polyunsaturated fatty acid mediators in diabetes and the metabolic syndrome.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106407
Blood ceramides as novel markers for renal impairment in systemic lupus erythematosus.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106348
Eicosanoids derived from cytochrome P450 pathway of arachidonic acid and inflammatory shock.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106377
VIP modulates the ALX/FPR2 receptor axis toward inflammation resolution in a mouse model of bacterial keratitis.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2018.12.001
Dietary omega-3 PUFA improved tubular function after ischemia induced acute kidney injury in mice but did not attenuate impairment of renal function.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106386
Flax seed oil reduced tumor growth, modulated immune responses and decreased HPV E6 and E7 oncoprotein expression in a murine model of ectopic cervical cancer.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.04.002
THE EFFECT OF THE EP3 ANTAGONIST DG-041 ON MALE MICE WITH DIET-INDUCED OBESITY.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106353
Neutral sphingomyelinase increases and delocalizes in the absence of Toll-Like Receptor 4: A new insight for MPTP neurotoxicity.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.03.004
Prostaglandin E2, a postulated mediator of neurovascular coupling, at low concentrations dilates whereas at higher concentrations constricts human cerebral parenchymal arterioles.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106389
Oxidative pathways of arachidonic acid as targets for regulation of platelet activation.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106382
Omega-3 fatty acids and docosahexaenoic acid oxymetabolites modulate the inflammatory response of equine recombinant interleukin1β-stimulated equine synoviocytes.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.02.007
Oral Resolvin D1 attenuates early inflammation but not intimal hyperplasia in a rat carotid angioplasty model.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106401
5-oxo-ETE activates migration of H295R adrenocortical cells via MAPK and PKC pathways.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106346
Increased pain and inflammatory sensitivity in growth hormone-releasing hormone (GHRH) knockout mice.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106362
Urinary prostaglandin D2 and E2 metabolites associate with abdominal obesity, glucose metabolism, and triglycerides in obese subjects.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106361
Formyl-peptide receptor 2 suppresses proliferation, migration and invasion in human extravillous trophoblastic cells.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106342
Prostaglandin E2 and an EP4 receptor agonist inhibit LPS-Induced monocyte chemotactic protein 5 production and secretion in mouse cardiac fibroblasts via Akt and NF-κB signaling.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106349
Lipoxin A4 inhibited the activation of hepatic stellate cells -T6 cells by modulating profibrotic cytokines and NF-κB signaling pathway.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106380
Detoxification and activating blood circulation decoction reduces restenosis involving the TLR4/NF-κB pathway after balloon injury.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2018.11.002
Do arachidonic acid metabolites affect apoptosis in bovine endometrial cells with silenced PPAR genes?
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106336
Regulation of nicotinic acetylcholine receptor α3 subtype in adipose tissue dysfunction.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.04.001
Seasonal expressions of COX-1, COX-2 and EP4 in the uteri of the wild Daurian ground squirrels (Spermophilus dauricus).
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106343
Interaction between PGI2 and ET-1 pathways in vascular smooth muscle from Group-III pulmonary hypertension patients.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106388
Role of sphingolipids in the pathogenesis of intrahepatic cholestasis.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106399
Metabolic studies of synaptamide in an immortalized dopaminergic cell line.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.02.002
Liquid chromatography-coupled mass spectrometry analysis of glutathione conjugates of oxygenated polyunsaturated fatty acids.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106350
The role of lipoxin in regulating tumor immune microenvironments.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106341
Enhancement by HSP90 inhibitor of PGD2-stimulated HSP27 induction in osteoblasts: Suppression of SAPK/JNK and p38 MAP kinase.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.03.002
A combination of LCPUFAs regulates the expression of miRNA-146a-5p in a murine asthma model and human alveolar cells.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.106378
Quantifying 1-deoxydihydroceramides and 1-deoxyceramides in mouse nervous system tissue.
来源期刊:Prostaglandins & other lipid mediatorsDOI:10.1016/j.prostaglandins.2019.02.005